Clinical Trial Update: A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH) [Phase 2]

View source ↗

Summary

This is a Phase 2b clinical trial update on Miricorilant for nonalcoholic steatohepatitis/metabolic dysfunction-associated steatohepatitis (MONARCH); the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Miricorilant (CORT118335)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH) | Phase 2 | Status: ACTIVE_NOT_RECRUITING